key: cord-0804140-yagfewdk authors: Erol, Muhammet Kazim; Bozdogan, Yigit Caglar; Suren, Elcin; Gedik, Birumut title: Treatment of a full-thickness macular hole and retinal detachment secondary to toxoplasma chorioretinitis that developed shortly after COVID-19: a case report date: 2022-01-06 journal: J Fr Ophtalmol DOI: 10.1016/j.jfo.2021.12.004 sha: 198a9f194a5c5b6a6e22169e7ae2a6e494ba4453 doc_id: 804140 cord_uid: yagfewdk Bien que la toxoplasmose oculaire soit généralement une infection spontanément résolutive, elle peut entraîner une réduction sévère de l'acuité visuelle en raison d'une inflammation intense du vitré ou d'une atteinte des structures du segment postérieur. Selon la gravité de l'inflammation intraoculaire, des complications graves, notamment la membrane épirétinienne ou le décollement de la rétine, peuvent se développer. Dans cet article, nous visons à présenter un cas compliqué à la fois par un trou maculaire de pleine épaisseur et un clivage rétinien secondaire à une choriorétinite toxoplasmique qui s'est développée peu de temps après la nouvelle maladie à coronavirus (COVID-19) et des discussions sur notre approche thérapeutique. Après que le patient ait été diagnostiqué sur la base d'un examen ophtalmologique de routine, d'une imagerie du fond d'œil et d'un examen sérologique, la récupération fonctionnelle et anatomique a été obtenue grâce à une antibiothérapie systémique et à une chirurgie vitréorétinienne. Le trou maculaire de pleine épaisseur et le décollement de la rétine sont des complications rares de la toxoplasmose oculaire. Cependant, il existe peu de publications dans la littérature concernant ces complications et leur traitement chirurgical. Dans ce rapport de cas, nous avons démontré le succès de la chirurgie vitréorétinienne associée à une antibiothérapie sur les complications du segment postérieur de la toxoplasmose oculaire. Although ocular toxoplasmosis is usually a self-limiting infection, it can lead to severe reduction in visual acuity due to intense vitreous inflammation or involvement of posterior segment structures. Depending on the severity of intraocular inflammation, serious complications, including epiretinal membrane or retinal detachment may develop. In this paper, we aim to present a case that complicated by both a full-thickness macular hole and retinal detachment secondary to toxoplasmosis chorioretinitis that developed shortly after the novel coronavirus disease (COVID-19) and discuss our treatment approach. After the patient was diagnosed based on a routine ophthalmological examination, fundus imaging, and serological examination, functional and anatomical recovery was achieved through systemic antibiotherapy and vitreoretinal surgery. Full-thickness macular hole and retinal detachment are rare complications of ocular toxoplasmosis. However, there are only few publications in the literature concerning these complications and their surgical treatment. In this case report, we demonstrated the success of vitreoretinal surgery combined with antibiotic therapy on the posterior segment complications of ocular toxoplasmosis. Ocular toxoplasmosis is the most common cause of infectious uveitis worldwide and is caused by Toxoplasma gondii, an obligate intracellular parasite. Ocular toxoplasmosis is responsible for 28% of all posterior uveitis cases (1). Acquired infection or re-exacerbation of congenital infection may be responsible for the development of these cases. The first complaints of these patients are usually unilateral floaters, blurred vision, and photophobia. The diagnosis is made clinically based on the observation of typical lesions in the fundus examination. Serology is also used to support the diagnosis and make a differential diagnosis (2, 3) . Although ocular toxoplasmosis is usually a self-limiting infection in immunocompetent individuals, it can lead to severe reduction in visual acuity due to intense vitreous inflammation or involvement of posterior segment structures. The typical presentation of the disease is focal necrotizing chorioretinitis, usually in one eye, which is adjacent to the old, pigmented scar and accompanied by vitritis. Posterior uveitis is often accompanied by granulomatous anterior uveitis. Depending on the severity of intraocular inflammation, serious complications, such as epiretinal membrane or retinal detachment may develop (1, 4). In this paper, we present a case complicated by a full-thickness macular hole and retinal detachment secondary to toxoplasmosis chorioretinitis that developed shortly after the novel coronavirus disease and discuss our treatment approach. In May 2021, a 30-year-old female patient presented to the Ophthalmology Clinic of Health Sciences University Antalya Training and Research Hospital with acute-onset unilateral low vision. The patient's anamnesis revealed that she had tested positive for COVID-19 two weeks earlier. The patient was emmetrope and the visual acuity in the left eye was at the level of hand movement, and intraocular pressure was normal. Her ophthalmological examination showed +2 cells in the anterior chamber and +2 vitritis in the left eye. In the fundus examination, in addition to two toxoplasmosis-specific classical chorioretinitis scars, there was an area of active chorioretinitis adjacent to the superior temporal arcuate vessels, one of which was of 2/3 optic disc size and located in the nasal of the optic disc and the other was of 1 optic disc size and located adjacent to the superior temporal arcuate vessel. Additionally, no retinal tear or rhegmatogenic lesion was observed in Page 6 of 16 J o u r n a l P r e -p r o o f the peripheral fundus examination of the patient. A full-thickness macular hole and secondary macula-off retinal detachment were also observed (Figures 1 and 2 ). The size of the fullthickness macular hole was 698 µm. Optomap wide-angle fundus imaging (Daytona, Optos®, UK), optical coherence tomography angiography (OCTA, AngioVue; Optovue, Inc, Fremont, CA), and fundus fluorescein angiography were performed. To support the diagnosis and to make a differential diagnosis, serological tests were performed. According to the findings, anti-toxoplasma IgG antibody was positive (470,30 IU/L) and anti-toxoplasma IgM antibody was negative (0.288 IU/L). In addition, the laboratory tests showed that the patient was negative for anti-HIV, anti-Herpes, anti-Varicella and anti-CMV antibodies and VDRL-RPR. The patient was diagnosed with toxoplasma chorioretinitis and started on oral trimethoprim/sulfamethoxazole (160/800 mg) twice a day and clindamycin 300 mg four times a day. After three days, 32 mg/day methylprednisolone was added to oral treatment. The patient was hospitalized, and vitreoretinal surgery was scheduled for the treatment of the macular hole and retinal detachment. Under general anesthesia, the patient underwent core vitrectomy with 23-gauge pars plana vitrectomy (PPV). Then posterior hyaloid membrane peeling, and peripheral vitrectomy were performed using 0.8mg/0.1 cc triamcinolone. After the internal limiting membrane (ILM) was visualized with ILM staining, it was peeled circularly from the fovea using 23gauge microforceps under decaline. The peeled ILM piece was placed into the macular hole using the inverted flap technique. Subretinal fluid was drained with single retinotomy from the extramacular region, and the retina was completely reattached. Subsequently, 360-degree retinal photocoagulation was performed. Then, liquid-air and air-gas tamponade exchange was applied. As gas, 16% SF6 was used. Surgery was terminated after the trocar sites were sutured. After surgery, the patient was placed in prone position for 10 days. Topically, drops containing antibiotics and steroids were applied for up to one month after surgery. Oral antibiotic treatment for toxoplasma was continued for six weeks. In the follow-up session undertaken on the 20th postoperative day, the visual acuity of the left eye was 20/400. Intraocular pressure was normal in both eyes, and no cells were observed in the anterior chamber. The retina was observed to be attached and the full- 6 ). Toxoplasma chorioretinitis is a self-limiting infection in immunocompromised individuals. Many patients without the involvement of posterior segment structures or development of severe intraocular inflammation can improve without treatment. However, the disease may progress very aggressively in immunosuppressed individuals (5) . In particular, the cellular immune system plays a major role in the body in protecting against T. gondii infections (6) . Although our patient did not have a known immunosuppressive condition, her anamnesis showed that she had recently contracted COVID-19 and recovered with treatment. There are not yet any reports describing an increase in T. gondii infections in patients with COVID-19. However, it is considered that the decrease in the functions of cellular immune system cells in individuals that have suffered from COVID-19 may pave the way for opportunistic infections (7). This suggests that our case having had a COVID-19 infection approximately two weeks earlier may have caused reactivation in ocular toxoplasmosis. At Macular hole is a defect that occurs in the fovea and involves all retinal layers (12). The prevalence of a macular hole secondary to ocular toxoplasmosis is very low, and a gold standard treatment has not yet been established. The mechanism of full-thickness macular hole formation secondary to toxoplasma chorioretinitis remains unclear. However, tractional forces caused by intraocular inflammation, atrophy around the lesion, and vitreomacular traction due to this atrophy are implicated in its pathogenesis (13, 14) . In the literature, there are four articles reporting the surgical results of a macular hole secondary to toxoplasma chorioretinitis. In these publications, a total of 14 cases were described, and macular holes were anatomically closed in all cases after surgery. Similarly, an increase in postoperative visual acuity was reported in all of these 14 cases (14) (15) (16) (17) . In one of these case reports, Ikeda et al. described the use of the inverted ILM flap technique in addition to PPV and ILM peeling as a surgical method. In the remaining 13 cases, standard macular hole surgery was performed. We also used the inverted ILM flap technique in our case and achieved anatomical success. It is suggested that the ILM placed in the macular hole with this technique acts as a bridge for degenerated retinal cells and contributes to the closure of the hole (14, 18) . One of the previously published 14 cases did not have successful closure of the macular hole with the first surgery, and thus second surgery was required (15). Tractional forces due to intraocular inflammation and atrophic retinal areas are responsible for the pathogenesis of retinal detachment, which is a rare complication that may develop secondary to toxoplasma chorioretinitis. There are various publications in the literature concerning the surgical correction of this complication, which can seriously threaten vision. scleral buckling or PPV with the use of silicone oil or endotamponade gas can be preferred as the surgical method. In our case, we preferred PPV with ILM peeling and gas endotamponade with SF6 since retinal detachment was accompanied by a macular hole. Postoperative results may vary depending on the condition of the macula, time between the development of detachment and surgery, and presence of proliferative vitreoretinopathy (19, 20) . According to the results of our second-month postoperative examination, our patients achieved anatomical and functional improvement. We consider that this study is important because it reports the first case in which a macular hole and retinal detachment secondary to J o u r n a l P r e -p r o o f ocular toxoplasmosis were seen together and describes the treatment process with medical and vitreoretinal surgery. In various publications, the probability of developing CNV in areas of old chorioretinal atrophy due to toxoplasma has been reported as 2-19%. However, CNV accompanying an already active toxoplasma lesion is a very rare condition. Cracks in Bruch's membrane and the choriocapillaris layer as a result of chorioretinitis are held responsible for the development of subretinal CNV. In addition to antibiotherapy for toxoplasma, intravitreal anti-VEGF injection is an important alternative used in treatment (21, 22) . In our patient, OCTA imaging revealed subretinal CNV in the active and old chorioretinitis areas in the superior temporal arcuate region. We administered a single dose of intravitreal anti-VEGF to the patient approximately three weeks after vitreoretinal surgery and determined that the size of CNV was decreased in the follow-up. However, we observed some subretinal fluid around the lesion even at two months after successful vitreoretinal surgery ( Figure 6 ). Macular holes are responsible for approximately 1% of all rhegmatogenous retinal detachment cases (23, 24), and the pathological myopia group constitutes the majority of these cases. Vitreomacular traction and tangential forces are effective in the mechanism of macular holes leading to retinal detachment (24). In our case, as mentioned above, tractional forces leading to the development of retinal detachment may have been associated with intraocular inflammation, chorioretinal atrophy, and macular holes. Another factor that may have played a role in the development of retinal detachment is CNV-related subretinal fluid. We consider that subretinal fluid accumulating in the superior temporal macula region due to CNV may have moved to the fovea center over time, triggering or accelerating the development of retinal detachment. Therefore, the reduction of the size of CNV and subretinal fluid with intravitreal anti-VEGF and successful vitreoretinal surgery are important in achieving anatomical and functional success. In conclusion, we consider that this ocular toxoplasmosis case complicated by a macular hole, retinal detachment, and CNV will contribute to the literature in terms of both its surgical and medical management and relationship with COVID-19. We look forward to further studies on this subject. Les auteurs déclarent n'avoir aucun lien d'intérêts en relation avec cet article Ocular toxoplasmosis Serologic tests in the diagnosis of presumed toxoplasmic retinochoroiditis Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management Ocular manifestations of toxoplasmosis The Hazards of Corticosteroid Monotherapy Heterogeneity in cellular and humoral immune responses against Toxoplasma gondii antigen in humans Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients Retinopathy following intravitreal injection of mice with MHV strain JHM Ocular tropisms of murine coronavirus (strain JHM) after inoculation by various routes COVID-19 and the eye immunity: lesson learned from the past and possible new therapeutic insights Toxoplasmic retinochoroiditis: clinical characteristics and visual outcome in a prospective study Macular Hole Secondary to Ocular Toxoplasmosis Treated Successfully by Vitrectomy with Inverted Internal Limiting Membrane Flap Macular hole associated with toxoplasmosis: a surgical case series. Retin Cases Brief Rep Internal limiting membrane graft in full-thickness macular hole secondary to macular telangiectasia type 2 Surgical outcomes of rhegmatogenous retinal detachment associated with ocular toxoplasmosis Choroidal Neovascularization as a Late Complication of Ocular Toxoplasmosis Coexisting choroidal neovascularization and active retinochoroiditis-an uncommon presentation of ocular toxoplasmosis Retınal detachment principles and practice